About MYS
Overview
MYS is a newly established brokerage entity that entered the market in May 2025, according to its registration records. The firm is registered in the United Kingdom under the name MYS, though it operates with a physical address in Dreux, France. At the time of this assessment, MYS has no publicly available website content or independent reviews, and its operational presence remains opaque.
Given the lack of any verifiable trading platform or client-facing materials, the broker's claims regarding its services must be treated with extreme caution. The entity appears to be in an early stage of development, with no track record or community feedback to substantiate its offerings.
Registration and Location
MYS lists its country of registration as the United Kingdom, but its registered address is located at au 10 rue du Gouverneur, 28100 Dreux, France. This discrepancy between the registration jurisdiction and the physical address raises questions about the true operational base and regulatory oversight. The broker's incorporation date of 6 May 2025 indicates it is less than six months old as of the time of this review.
Importantly, MYS is not licensed by any financial regulator, whether in the UK, France, or elsewhere. The absence of regulation means that traders have no recourse to any ombudsman or compensation scheme in the event of disputes or financial loss. This is a significant red flag for any prospective client.
Account Types
According to the limited information available, MYS claims to offer three account types: Standard, Raw Spread, and Raw Spread (cTrader). However, no details are provided regarding minimum deposit requirements, maximum leverage, spreads, or commissions for any of these accounts. The mention of cTrader suggests the broker may intend to support the popular cTrader platform, but this remains unconfirmed.
Without concrete specifications, traders cannot evaluate the cost structure or suitability of these accounts. The lack of transparency around such fundamental trading conditions is a common characteristic of high-risk or unestablished brokers.
Instruments and Platforms
No information is currently available regarding the financial instruments offered by MYS, such as forex pairs, indices, commodities, or cryptocurrencies. Similarly, the broker has not disclosed which trading platforms are supported beyond the cTrader mention in one account name. There are no details on web-based, desktop, or mobile trading solutions.
This absence of disclosure makes it impossible to determine whether MYS caters to a specific asset class or trader demographic. In our assessment, the lack of basic product information suggests either a pre-launch stage or an intentional withholding of key details from the public.
Risk Assessment
MYS receives a Scam Risk Score of 75 out of 100 from FXCanary, categorised as 'Severe'. This rating reflects the broker's complete lack of regulatory oversight, extremely short operational history, and absence of verifiable information from independent sources. The combination of these factors places it among the highest risk brokers in our database.
Traders considering MYS should be aware that there are no safeguards in place to protect client funds. Unregulated brokers are not subject to capital adequacy requirements, segregation of client money, or audit obligations. In the event of a dispute or insolvency, clients have no avenue for compensation or legal recourse.
Conclusion
MYS presents as an early-stage, unregulated brokerage with minimal publicly available information. Its UK registration does not equate to regulatory oversight, and the French address further complicates its jurisdictional accountability. The three account types advertised lack any concrete details, making due diligence impossible.
Until MYS provides clear licensing, transparent trading conditions, and a verifiable track record, it cannot be recommended for any form of live trading. Traders are strongly advised to avoid depositing funds with this entity given the severe risk profile.
Overview compiled by FXCanary from regulatory records and public data. full MYS review